Ieq Capital LLC boosted its stake in McKesson Corporation (NYSE:MCK – Free Report) by 24.6% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 25,134 shares of the company’s stock after purchasing an additional 4,968 shares during the period. Ieq Capital LLC’s holdings in McKesson were worth $21,459,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in shares of McKesson during the second quarter worth $8,156,743,000. Bank of America Corp DE acquired a new stake in shares of McKesson in the second quarter valued at $998,896,000. Legal & General Group Plc purchased a new stake in shares of McKesson in the 2nd quarter valued at $656,566,000. The Manufacturers Life Insurance Company purchased a new stake in shares of McKesson in the 2nd quarter valued at $651,462,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of McKesson in the 2nd quarter valued at $599,060,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.
McKesson Trading Down 2.0%
McKesson stock opened at $1,062.62 on Friday. McKesson Corporation has a twelve month low of $723.68 and a twelve month high of $1,121.50. The stock’s fifty day simple moving average is $970.87 and its 200-day simple moving average is $879.62. The firm has a market capitalization of $122.69 billion, a P/E ratio of 27.32, a P/E/G ratio of 1.84 and a beta of 0.27.
McKesson (NYSE:MCK – Get Free Report) last released its earnings results on Wednesday, November 4th. The company reported $11.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.72 by $0.96. The firm had revenue of $110.96 billion during the quarter, compared to analyst estimates of $109.90 billion. McKesson had a negative return on equity of 202.94% and a net margin of 1.12%. McKesson’s revenue was up 7.5% compared to the same quarter last year. During the same period last year, the business posted $9.86 earnings per share. Sell-side analysts predict that McKesson Corporation will post 46.09 earnings per share for the current year.
McKesson Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Tuesday, December 1st will be given a $0.94 dividend. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $3.76 dividend on an annualized basis and a yield of 0.4%. McKesson’s dividend payout ratio (DPR) is currently 9.67%.
Insider Transactions at McKesson
In other news, CAO B Jr sold 111 shares of McKesson stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $891.45, for a total value of $98,950.95. Following the completion of the transaction, the chief accounting officer owned 521 shares in the company, valued at approximately $464,445.45. This trade represents a 17.56% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Francisco Fraga sold 650 shares of the business’s stock in a transaction dated Thursday, November 5th. The stock was sold at an average price of $1,102.96, for a total value of $716,924.00. Following the transaction, the executive vice president directly owned 4,414 shares of the company’s stock, valued at approximately $4,868,465.44. This represents a 12.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 2,161 shares of company stock worth $2,242,515 in the last ninety days. 0.06% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on the company. Weiss Ratings upgraded McKesson from a “buy (b)” rating to a “buy (b+)” rating in a report on Monday, November 9th. Bank of America lifted their target price on McKesson from $950.00 to $1,050.00 in a research report on Thursday, August 6th. Robert W. Baird set a $1,015.00 price target on shares of McKesson in a research note on Thursday, August 6th. JPMorgan Chase & Co. increased their price target on shares of McKesson from $1,042.00 to $1,255.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 10th. Finally, Wells Fargo & Company raised their price objective on shares of McKesson from $812.00 to $933.00 and gave the company an “equal weight” rating in a research note on Tuesday, August 11th. Fifteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $1,054.12.
Read Our Latest Analysis on MCK
McKesson Profile
McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers. The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care. Founded in 1833, McKesson serves customers primarily in the United States and Canada.
Featured Articles
- Five stocks we like better than McKesson
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
